Literature DB >> 3664093

Apparent affinity of some 8-phenyl-substituted xanthines at adenosine receptors in guinea-pig aorta and atria.

M G Collis1, K A Jacobson, D M Tomkins.   

Abstract

1 Some 8-phenyl-substituted, 1,3 dipropyl xanthines have previously been demonstrated to have a 20-400 fold greater affinity for A1 binding sites in rat CNS membranes than for A2 adenosine receptors in intact CNS cells from guinea-pigs. In the present study these compounds (1,3, dipropyl-8-phenylxanthine: DPPX; 1,3 dipropyl-8-(2 amino-4-chlorophenyl) xanthine: PACPX; 8-(4-(2-amino-ethyl)amino) carbonyl methyl oxyphenyl)-1,3-dipropylxanthine: XAC; and D-Lys-XAC) together with two that have not been reported to exhibit A1-receptor selectively (8-(p-sulphophenyl)theophylline: 8-PST; 8-(4-carboxy methyl oxyphenyl)-1,3-dipropylxanthine: XCC) have been evaluated as antagonists of the effects of 2-chloroadenosine in two isolated cardiovascular tissues. 2 The isolated tissues used were guinea-pig atria (bradycardic response) and aorta (relaxation), which are thought to possess A1 and A2 adenosine receptors, respectively. 3 All the xanthines antagonized responses evoked by 2-chloroadenosine in both tissues but did not affect responses evoked by acetylcholine (atria) or sodium nitrite (aorta). 4 The xanthines, 8-PST, XAC, D-Lys XAC, XCC and DPPX appeared to be competitive antagonists of the effects of 2-chloroadenosine, as Schild plot slopes did not differ significantly from unity. The 1,3-dipropyl substituted compounds had pA2 values from 6.5 to 7.4 and were more potent than the 1,3 dimethyl substituted 8-PST (pA2 4.9 to 5). 5 For individual xanthines, there was no difference between pA2 values obtained in the atria and in the aorta. 6 Responses evoked by 2-chloroadenosine in atria and aorta were antagonized to a similar degree by PACPX (1 microM). The agonist dose-ratio evoked by 10 microM PACPX was no greater than that evoked by 1 microM of the xanthine in both tissues. This was probably a consequence of the limited aqueous solubility of PACPX. 7. These results fail to demonstrate A, receptor selectivity for DPPX, XAC, D-Lys XAC or PACPX in tissues from the guinea-pig. The A, selectivity previously found for these compounds may therefore be due to their high affinity for binding sites in rat CNS cell membranes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664093      PMCID: PMC1853619          DOI: 10.1111/j.1476-5381.1987.tb11297.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  THE UPTAKE OF ATROPINE AND RELATED DRUGS BY INTESTINAL SMOOTH MUSCLE OF THE GUINEA-PIG IN RELATION TO ACETYLCHOLINE RECEPTORS.

Authors:  W D PATON; H P RANG
Journal:  Proc R Soc Lond B Biol Sci       Date:  1965-08-24

2.  Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  J Neurochem       Date:  1979-11       Impact factor: 5.372

3.  On the mechanism of activation of muscarinic K+ channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins.

Authors:  Y Kurachi; T Nakajima; T Sugimoto
Journal:  Pflugers Arch       Date:  1986-09       Impact factor: 3.657

4.  1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors.

Authors:  J W Daly; W Padgett; M T Shamim; P Butts-Lamb; J Waters
Journal:  J Med Chem       Date:  1985-04       Impact factor: 7.446

5.  Structure-activity relationships for N6-substituted adenosines at a brain A1-adenosine receptor with a comparison to an A2-adenosine receptor regulating coronary blood flow.

Authors:  J W Daly; W Padgett; R D Thompson; S Kusachi; W J Bugni; R A Olsson
Journal:  Biochem Pharmacol       Date:  1986-08-01       Impact factor: 5.858

6.  Comparison of the potency of 8-phenyltheophylline as an antagonist at A1 and A2 adenosine receptors in atria and aorta from the guinea-pig.

Authors:  M G Collis; D B Palmer; V L Saville
Journal:  J Pharm Pharmacol       Date:  1985-04       Impact factor: 3.765

7.  The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors.

Authors:  T P Kenakin
Journal:  Br J Pharmacol       Date:  1984-01       Impact factor: 8.739

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  PACPX--a substituted xanthine--antagonizes both the A1 and A2 subclasses of the P1-purinoceptor: antagonism of the A2 subclass is competitive but antagonism of the A1 subclass is not.

Authors:  G Burnstock; C H Hoyle
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

10.  Adenosine relaxes the aorta by interacting with an A2 receptor and an intracellular site.

Authors:  M G Collis; C M Brown
Journal:  Eur J Pharmacol       Date:  1983-12-09       Impact factor: 4.432

View more
  21 in total

1.  Characterization of the P1-purinoceptors mediating contraction of the rat colon muscularis mucosae.

Authors:  S J Bailey; D Hickman; S M Hourani
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

2.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

3.  FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.

Authors:  R G Humphries; W Tomlinson; A H Ingall; P A Cage; P Leff
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

4.  Cerebral ischemia in gerbils: postischemic administration of cyclohexyl adenosine and 8-sulfophenyl-theophylline.

Authors:  D K von Lubitz; P J Marangos
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

5.  Subtypes of purinoceptors in rat and dog urinary bladder smooth muscles.

Authors:  H Suzuki; S Kokubun
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

6.  Further analysis of the mechanisms underlying the tracheal relaxant action of SCA40.

Authors:  S J Cook; K Archer; A Martin; K H Buchheit; J R Fozard; T Müller; A J Miller; K R Elliott; R W Foster; R C Small
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

7.  Direct effects of adenylyl 5'-(beta,gamma-methylene)diphosphonate, a stable ATP analogue, on relaxant P1-purinoceptors in smooth muscle.

Authors:  S M Hourani; S J Bailey; J Nicholls; I Kitchen
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

8.  A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide.

Authors:  A Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

9.  1,3,8- and 1,3,7-substituted xanthines: relative potency as adenosine receptor antagonists at the frog neuromuscular junction.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

10.  Cross talk between receptors mediating contraction and relaxation in the arterioles but not the dilator muscle of the rat iris.

Authors:  D J Gould; M Vidovic; C E Hill
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.